News & Updates

A large multisite evaluation found that produce prescriptions were associated with statistically significant and clinically meaningful health improvements, including clinical biomarkers of cardiometabolic health, in adults and children.

The selective small molecule inhibitor of lipoprotein(a) (Lp[a]) formation muvalaplin helps reduce Lp(a) levels by up to 65 percent without safety and tolerability signals, as shown in the results of a phase I trial.

Individuals with microscopic colitis have a twofold greater risk of rheumatoid arthritis (RA) compared with those in the general population, as reported in a study.

Multistrain probiotics confer significant mortality-reduction benefit in preterm infants, according to the results of a network meta-analysis.

Treatment with 5-methyltetrahydrofolate (5-MTHF) significantly enhances the effect of propranolol in reducing hepatic venous pressure gradient (HVPG) in patients with cirrhosis and portal hypertension, a recent study has shown.

The combination of hepatocyte-derived biomarkers and FibroTest or model for end-stage liver disease (MELD) scores can help identify patients with Child-Pugh class A alcohol-related cirrhosis who are prone to liver-related events at 2 years, reports a study.